STAGE IV FALLOPIAN TUBE CANCER AJCC V8
Clinical trials for STAGE IV FALLOPIAN TUBE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV FALLOPIAN TUBE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV FALLOPIAN TUBE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Electric field device joins drug combo to fight advanced cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to see i…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New hope for Hard-to-Treat ovarian cancer: PLX038 trial launches
Disease control Recruiting nowThis study tests a drug called PLX038 in people with ovarian, fallopian tube, or peritoneal cancer that has spread and no longer responds to platinum chemotherapy. The goal is to see if PLX038 can shrink tumors by blocking enzymes that cancer cells need to grow. About 43 adults w…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Fitbit fitness: could a smartwatch help cancer patients live better?
Symptom relief Recruiting nowThis study tests whether a personalized, automated exercise program using a Fitbit can help people with advanced ovarian or endometrial cancer become more active. Researchers want to see if reaching 150 minutes of moderate exercise per week improves quality of life, physical func…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC